Your browser doesn't support javascript.
loading
L1198F Mutation Resensitizes Crizotinib to ALK by Altering the Conformation of Inhibitor and ATP Binding Sites.
Li, Jian; Sun, Rong; Wu, Yuehong; Song, Mingzhu; Li, Jia; Yang, Qianye; Chen, Xiaoyi; Bao, Jinku; Zhao, Qi.
Afiliação
  • Li J; School of Medicine, Chengdu University, Chengdu 610106, China. lijian01@cdu.edu.cn.
  • Sun R; College of Life Sciences and Key Laboratory for Bio-Resources of Ministry of Education, Sichuan University, Chengdu 610064, China. sunrong198982@163.com.
  • Wu Y; School of Information Science and Engineering, Chengdu University, Chengdu 610106, China. yuehongwu.cdu@foxmail.com.
  • Song M; School of Medicine, Chengdu University, Chengdu 610106, China. songmingzhu@cdu.edu.cn.
  • Li J; School of Medicine, Chengdu University, Chengdu 610106, China. lijia0619@foxmail.com.
  • Yang Q; Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610052, China. qianyeyang@foxmail.com.
  • Chen X; College of Pharmacy and Biological Engineering, Chengdu University, Chengdu 610106, China. xiaoyichen.cdu@foxmail.com.
  • Bao J; College of Life Sciences and Key Laboratory for Bio-Resources of Ministry of Education, Sichuan University, Chengdu 610064, China. baojinku@scu.edu.cn.
  • Zhao Q; College of Pharmacy and Biological Engineering, Chengdu University, Chengdu 610106, China. zhaoqi@cdu.edu.cn.
Int J Mol Sci ; 18(3)2017 Feb 24.
Article em En | MEDLINE | ID: mdl-28245558

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pirazóis / Piridinas / Códon / Receptores Proteína Tirosina Quinases / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Domínios e Motivos de Interação entre Proteínas / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pirazóis / Piridinas / Códon / Receptores Proteína Tirosina Quinases / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Domínios e Motivos de Interação entre Proteínas / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China